IOVA Q1 2022 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$92M

Net Income

-$92M

EPS (Diluted)

$-0.58

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$85M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$701M

Total Liabilities

$149M

Stockholders' Equity

$552M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$92M	-$76M	-21.4%
Net Income	-$92M	-$75M	-21.4%